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ABSTRACT
Background: Grass and birch pollens are known to induce asthma. However there are few reports about
other pollen-induced asthma. Japanese cedar is the most common allergen in rhinitis in Japan but is controver-
sial on whether it can provoke asthma.
Methods: To clarify Japanese cedar pollen-induced asthma, we studied adult patients who were sensitized
only to the Japanese cedar (CAP-RAST > = 2) and had symptoms of asthma during the cedar season. We de-
fined cedar asthma as a patient who satisfied the 2 criteria mentioned above.
Results: We found 6 adult asthma patients who fulfilled the two criteria. Five patients suffered from cedar polli-
nosis in addition to asthma, and 1 patient had no pollinosis. The cedar pollinosis preceded asthma in 3 cases
and occurred at almost the same time in the other 2 cases. Pulmonary function was normal in these cases
(FEV 1%, mean ± SD, 76.5 ± 10%), with a high threshold value in the non-specific airway hypersensitivity test
(Ach-PC20, 2,696 to 20,000 μgml, 9294 ± 2) and low total IgE (101 ± 86 IUml) . In the allergen provocation
test, 3 subjects showed both an immediate and late asthmatic reaction.
Conclusions: We concluded that Japanese cedar pollen could provoke not only pollinosis but also asthma in
adults.
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INTRODUCTION
In Japan, we are exposed to Japanese cedar (Cryp-
tomeria Japonica, JC) pollen much more than any
other pollen during the spring. It is well known that
the cedar pollen plays a definite role in provoking al-
lergic rhinitis. On the other hand, it is controversial
whether cedar pollen can develop asthma. Because
many asthma patients are sensitized not only to the
cedar but also to other allergens, we could not con-
clude that cedar pollen was a causative allergen. We
found 6 adult patients who were sensitized to only JC
and in whom asthma developed in the spring. We
performed some tests on the patients to study their
clinical characteristics.
METHODS
DEFINITION OF CEDAR ASTHMA
We defined a patient as a Japanese cedar asthma pa-
tient, if he or she satisfied the following criteria. 1)
Being sensitized to the Japanese cedar pollen aller-
gen (RAST score ≧2) and not to any other allergens
which may develop asthma. 2) Having asthma symp-
toms, such as difficulty in breathing and wheezing oc-
curring in spring and recovering completely after the
season without any medications.
INTRA-DERMAL TEST
We used the Japanese cedar allergen extract (1 : 20
wv) produced by Hollister-Stier Co. (3525 N Regal
Street, Spokane, WA 99207-5788) in the intra-dermal
test. This 10,000 allergy unit extract contains about
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4.4 μgml of major allergen, Cry j 1.1 We applied
other allergen extracts, including 7 pollens (sage-
brush, orchard grass, alder, ragweed, oak, Japanese
hop, zelkova), 8 molds (Aspergillus, Alternaria, Cla-
dosporium, Penicillium, Malasettia, Neurospora,
Trichophyton, Aureobasidium), house-dust, house-
dust mites and 8 animal allergens (dog, cat, rat,
mouse, hamster, guinea-pig, horse, rabbit). With the
exception of JC, orchard grass, sagebrush and house-
dust mite, all other allergen extracts were produced
by Torii Pharmaceutical Co. (Tokyo, Japan). Concen-
trations of testing allergen extracts were 1 : 10,000 w
v in molds and mites and 1 : 1,000 wv in other aller-
gens. If results showed both the mean wheal≧9 mm
and flare diameter≧20 mm, the test was considered
to be positive. The patients being sensitized to other
allergens which may provoke asthma were excluded
from this study.
BRONCHIAL PROVOCATION TEST (BPT)
Non-specific and allergen specific BPT were per-
formed by Japanese standard tidal breathing
method.2 Patients were asked to stop taking all medi-
cations at least 12 hours before the BPT. Non-specific
airway hypersensitivity test was done before the aller-
gen specific BPT.
1. Non-specific BPT with Acethylcholine
The non-specific BPT was performed, using nebu-
lized acethylcholine solution, inhaled for 2 minutes,
starting at a dose of 56 μgml. Acethylcholine con-
centration was doubled to a maximal concentration of
20,000 μgml. We performed spirometry immediately
after the inhalation. The spirometry was done before
and after inhaling nebulized 0.9% saline solution
(baseline) and each dose of acethylcholine until a 20%
fall in FE1.0 from the baseline occurred, or until a
maximal dose of 20,000 μgml was reached.
2. Allergen Specific BPT
We used the same extract in allergen BPT as used in
the intra-dermal test. Because Hollister-Stier’s 1 : 20
vw JC allergen extract contains 50% glycerin and
may cause non-specification airway contraction, we
therefore reduced the glycerin content to 0.5% by di-
alysis and adjusted it to a proper concentration. The
maximum concentration was 1 : 100 wv. If there was
equal to or more than 20% fall in FEV 1.0 from the
baseline at 10 minutes after inhalation, we found an
early asthmatic reaction (EAR) to be positive. Late
asthmatic reaction (LAR) was evaluated as follows.
On the day before BPT, a monitoring of diurnal vari-
ations using Mini-Wright peak expiratory flow meter
was performed every hour from 9:00 a.m. to 9:00 p.m.
After the EAR evaluation, the patients returned home
and measured PEFR every hour until at least 9:00
p.m. If a decrease in PEFR later than 1:00 p.m. was
equal to or greater than a 15% decrease (3 hours later
after completion of the inhalation test) and there was
no fall in the PEFR on the day before the allergen
challenge (control day), we judged that LAR was posi-
tive. We informed all patients about the allergen BPT
and performed the test on patients who agreed to tak-
ing it. The allergen BPT was carried out in spring.
RESULTS
1. CASE REPORT
A 52-year-old woman (case 1 in Table 1) attended our
hospital. She has been suffering from pollinosis since
she was 30 years old. She experiences sneezing, wa-
tery rhinorrea, stuffed nose and itching eyes from
February to April every year. In 1995, she has been
experiencing a productive cough from March fol-
lowed by a difficulty in breathing. She visited our hos-
pital for a detailed examination on April 18th.
According to the patient’s past history, she has suf-
fered from no diseases except for pollinosis. She has
a brother who is an asthma patient. Physical examina-
tion revealed her reddish and swollen nose and no
adventitious lung sounds. According to Hansel’s stan-
dard,3 sputum eosinophil count was 2 plus positive.
The pulmonary function test was normal. We ob-
served an 18% increase in the FEV 1.0 in the airway
reversibility test using 2.5 mg salbutamol inhalation.
The provocative concentration of acetylcholine which
reduced FEV 1.0 by 20% from the baseline (Ach-PC
20) was 8,192 γml. In the intra-dermal test, the pa-
tient tested negative in all allergen extracts except for
JC pollen. CAP-RAST test was positive in JC and
negative in other allergens. In the cedar allergen
BPT, she showed both EAR and LAR (Fig. 1). She
was treated with β-stimulant and an oral xanthine de-
rivative and recovered from asthma symptoms with-
out any medication after 10th of May.
2. CHARACTERISTICS OF THE JAPANESE CE-
DAR ASTHMATIC PATIENTS
We have summarized the clinical characteristics of
the 6 JC pollen asthma patients (Table 1). All patients
began experiencing asthma symptoms from spring,
recovered in June and since then, have been com-
pletely free from dypnoeic episodes, chest tightness,
cough, and wheezing at night without any medica-
tions. They consisted of 1 man and 5 women ranging
from 26 to 52 years of age. Except for 1 subject, 5 had
JC pollinosis. Three of the 6 had pollinosis before
they were given a diagnosis of asthma. Only 1 patient
had a family history of allergies.
The CAP-RAST scores ranged from 3 to 6. Lung
function test revealed that the %VC ranged from 114
to 89% (105 ± 7%) and the FEV 1% ranged from 59 to
95% (77 ± 10%). The total IgE ranged from 17 to 227
IUml (mean ± S.D. 101 ± 86 IUml). The Ach-PC20
ranged from 2,696 to 20,000 μgml (9294 ± 2). We
performed an allergen inhalation test for 3 subjects.
All subjects showed both EAR and LAR.
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Fig. 1 Bronchial provocation test with Japanese cedar pol-
len alergen extract. Figure shows bronchial provocation test 
with Japanese cedar polen extract in case 1. She exhibited 
both early and late asthmatic reaction. Early asthmatic reac-
tion is evaluated with FEV1.0 at 10 minutes after the aler-
gen inhalation. When FEV1.0 fals to equal or for more than 
15%, early asthmatic reaction is considered to be positive. 
After the evaluation of early asthmatic reaction, the patient 
returns home and measures the peak expiratory flow rate 
every hour with Mini-Wright peak flow meter at least until 9 
p.m. (closed circle). If a peak flow value fals to equal or for 
more than 15% from the control day (open circle, the day be-
fore the chalenge) 3 hours after test completion, a late asth-
matic reaction is considered to be positive.
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Table 1 Characteristics of Japanese cedar polen-induced asthma
CAP-
RAST 
score
IgE (IU/ml)BPTFHFEV1.0%%VCAch-PC20 (μg/ml)
Polinosis 
onset age 
(yo)
Asthma 
onset 
age (yo)
Asthma 
symptoma-
tic month
Age/
GenderName
6NDDualN71112 819230523―552/F1) FH
3 17DualN7910120000N472―347/F2) KA
3 35NDN59 89ND38383―544/M3) TS
4227DualN851142000014323―635/F4) KI
6189NDN70104 78503133333/F5) EW
3 36NDN95111 269626262―526/F6) NN
4.2 ± 1.2101 ± 8677 ± 10105 ± 79294 ± 240 ± 8
Asthma symptomatic month, 2 (February) ―6 (June); yo, year-old; Ach-PC20, Acethyl-choline concentration at 20% fal in FEV1.0 from 
baseline value; BPT, Bronchial Provocation Test with Japanese cedar alergen extract (month when BPT done); Dual, Dual Asthmatic Re-
action (both Early Asthmatic Reaction and Late Asthmatic Reaction); FH, Family History on alergic diseases (asthma, alergic rhinitis, 
atopic dermatitis); N, non; ND, not done.
DISCUSSION
Some pollen increases the risk of hospital admission
for asthma.4-10 These reports provoked us to pay at-
tention to the relationship between pollen and
asthma.11 However we have little knowledge about
pollen-induced asthma other than grass and
birch.5,12,13
In our data, about 80% of adult rhinitis patients and
60% of adult asthma patients are sensitized to Japa-
nese cedar pollen in Japan. We had two reasons why
we could not prove that the JC pollen could cause
asthma. We had never seen that the pollen sensitized
asthma patients with pollinosis complained of worsen-
ing in their asthma symptoms distinctly during the
season. With the exception of a few children,14 a dis-
cordance of asthma symptoms and the pollen season
has made an obscure correlation between the cedar
pollen and asthma in adult patients. These asthma pa-
tients have already had some anti-asthmatic medica-
tions before an evaluation of the cedar pollen affect
on asthma was made. The medications may make it
unclear to determine what caused the worsening in
asthma symptoms. Another reason is the multiple
sensitization to other aero-allergens. We see many
asthma patients who are sensitized to other spring
aero-allergens and or perennial allergens. The multi-
ple sensitizations make it difficult to decide which al-
lergen is responsible for causing asthma.
If we give a diagnosis of JC pollen induced asthma
to a subject, we need to show that at least two criteria
have been met. First, patients must be sensitized to
the pollen. Second, the asthma symptoms need to co-
incide with the pollen season. We believe that an al-
lergen provocation test is not necessary when making
a diagnosis.15 If a patient is sensitized to pollen, he or
she has the pollen specific IgE on mucosal mast cells
in the lower respiratory tract and may show a bronco-
constriction in the allergen inhalation test. The most
important criterion is that a change in asthma symp-
toms coincides with the air-borne pollen count. For
example, in rhinitis, we observed that many patients
sensitized to JC pollen alone have rhino-conjunctivitis
symptoms only during the spring. Therefore it is easy
to make a diagnosis of JC pollinosis.
In 1995, we had an extremely high JC pollen count,
10 to 20 fold more than the average year and discov-
ered 6 JC pollen asthma patients. It can be said that
the higher the pollen counts, the higher the risk of
asthma worsening.9 The existence of JC pollen
Maeda Y et al.
416 Allergology International Vol 57, No4, 2008 www.jsaweb.jp
Fig. 2 Morphology of the Japanese cedar polen. The 
Japanese cedar polen grain is about 30 μm size in diameter 
and covered with a numerous number of fine particles, 
caled orbicles, which comes of easily from the polen 
surface.
asthma shows that the Japanese cedar is a novel pol-
len which can provoke asthma. Generally, pollen
grains are too large to penetrate into the lower respi-
ratory tract. Rosenberg reported that an intact pollen
grain itself hardly provoked asthma symptoms but
the crushed pollen could induce asthma.16 Therefore,
a minute particle may have a key role in provoking
asthma.
Allergenic activities of small particles on grass pol-
len and birch have been studied.17-19 These small par-
ticles are reported to be of micron size and consid-
ered to be a starch granule which consists of the pol-
len grain. Grass pollen adsorbs water during a thun-
der storm and then bursts4 and disperses the inner
starch granule into the atmosphere. The starch gran-
ule contains a major grass allergen, Lol p V,20 which
can provoke asthma attacks.
The JC pollen grain has a unique form and is about
30 micrometers in diameter (Fig. 2)21 and is too large
to penetrate into the lower respiratory tract. There-
fore, we believe that there might be some submi-
cronic components in JC pollen. Such a small particle
exists in the atmosphere during the cedar season22
and disperses along with the pollen grain itself.23
This small component can pass through a 5 μm filter
and contains Cry j 1 allergen activity and is thought to
be an orbicle which adheres to the pollen surface.24
These findings suggest that other pollens which have
a similar morphology, as in the Japanese cedar pol-
len, can induce asthma. The large pollen gain and a
crushed one may be inhaled into lower airway respi-
ratory tract likely to induce an asthma attack.
There may be other mechanisms which induce pol-
len asthma. One attractable hypothesis is that JC
asthma patients are more sensitive to Cry j 1 allergen
which is the only allergen of the orbicle, and not sen-
sitive to Cry j 2 which is the only allergen of the pol-
len starch granule. We must investigate that there is
a difference in allergen sensitivity between the
asthma and pollinosis patients. A pollinosis patient
without asthma shows allergic inflammation in the
lower respiratory tract after the pollen season.25-27 It
is unclear what the main mechanism of allergic in-
flammation in the lower airway is, and its indirect af-
fect on upper airway inflammation or direct allergen
inhalation. We require further study on the relation-
ship between pollen and asthmatic symptoms.
We conclude that the Japanese cedar pollen can
provoke not only pollinosis but also asthma in adults.
Further studies on cedar asthma, may add a novel re-
lationship to pollen and asthma.
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